Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-05 Sale | 2024-11-07 7:12 pm | AVENUE THERAPEUTICS INC. | ATXI | KRANZLER JAY D Director | 61 | $2.24 | $137 | 559 (Direct) | View |
2024-09-27 Purchase | 2024-10-01 4:15 pm | AVENUE THERAPEUTICS INC. | ATXI | KRANZLER JAY D Director | 500 | $2.4994 | $1,250 | 620 (Direct) | View |
2023-12-11 Sale | 2023-12-13 4:02 pm | AVENUE THERAPEUTICS INC. | ATXI | Davidow Robert L 10% Owner | 617,000 | $0.14029 | $86,560 | 761,000 (Indirect Direct) | View |
2023-09-08 Purchase | 2023-09-12 09:03 am | AVENUE THERAPEUTICS INC. | ATXI | ROSENWALD LINDSAY A MD Director | 348,675 | $0.72 | $251,046 | 354,318 (Direct) | View |
2023-09-08 Purchase | 2023-09-12 09:02 am | AVENUE THERAPEUTICS INC. | ATXI | Fortress Biotech Inc. 10% Owner | 418,410 | $0.72 | $301,255 | 1,032,390 (Direct) | View |
2022-10-11 Sale | 2022-10-13 8:52 pm | AVENUE THERAPEUTICS INC. | ATXI | InvaGen Pharmaceuticals Inc. 10% Owner | 388,888 | $7.714 | $2,999,882 | 0 (Indirect Direct) | View |
2021-09-15 Sale | 2021-09-15 4:03 pm | AVENUE THERAPEUTICS INC. | ATXI | Vazzano Joseph Walter Chief Financial Officer | 7,160 | $1.62 | $11,599 | 65,252 (Direct) | View |
2021-05-06 Purchase | 2021-05-07 08:02 am | AVENUE THERAPEUTICS INC. | ATXI | Herskowitz Neil Director | 2,500 | $3.99 | $9,975 | 134,724 (Direct) | View |
2020-08-20 Sale | 2020-08-21 4:15 pm | AVENUE THERAPEUTICS INC. | ATXI | Vazzano Joseph Walter Chief Financial Officer | 3,840 | $12.13 | $46,579 | 57,412 (Direct) | View |
2020-03-09 Purchase | 2020-03-10 4:42 pm | AVENUE THERAPEUTICS INC. | ATXI | Vazzano Joseph Walter Chief Financial Officer | 3,389 | $7.9615 | $26,982 | 61,252 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-09-23 Option Award | 2024-09-25 4:59 pm | N/A 2034-09-23 | AVENUE THERAPEUTICS INC. | ATXI | ROSENWALD LINDSAY A MD Director | 30,000 | $0 | 30,000 (Direct) | View |
2024-09-23 Option Award | 2024-09-25 4:57 pm | N/A 2034-09-23 | AVENUE THERAPEUTICS INC. | ATXI | Herskowitz Neil Director | 30,000 | $0 | 30,000 (Direct) | View |
2024-09-23 Option Award | 2024-09-25 4:55 pm | N/A 2034-09-23 | AVENUE THERAPEUTICS INC. | ATXI | Oltmans Curtis Gale Director | 30,000 | $0 | 30,000 (Direct) | View |
2024-09-23 Option Award | 2024-09-25 4:55 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | MacLean Alexandra Chief Executive Officer | 170,000 | $0 | 170,000 (Direct) | View |
2024-09-23 Option Award | 2024-09-25 4:54 pm | N/A 2034-09-23 | AVENUE THERAPEUTICS INC. | ATXI | KRANZLER JAY D Director | 30,000 | $0 | 30,000 (Direct) | View |
2024-09-23 Option Award | 2024-09-25 4:53 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Jin David Interim PFO and COO | 65,000 | $0 | 65,000 (Direct) | View |
2024-09-23 Option Award | 2024-09-25 4:53 pm | N/A 2034-09-23 | AVENUE THERAPEUTICS INC. | ATXI | Charles Faith L. Director | 30,000 | $0 | 30,000 (Direct) | View |
2024-04-16 Option Award | 2024-04-17 4:05 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Fortress Biotech Inc. 10% Owner | 413,507 | $0 | 3,547,393 (Direct) | View |
2024-01-02 Option Award | 2024-01-03 4:27 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Fortress Biotech Inc. 10% Owner | 2,101,496 | $0 | 3,133,886 (Direct) | View |
Ownership | 2023-11-28 4:01 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Davidow Robert L 10% Owner | 0 | $0 | 1,926,800 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 4:10 pm | N/A 2033-06-30 | AVENUE THERAPEUTICS INC. | ATXI | Charles Faith L. Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 4:09 pm | N/A 2033-06-30 | AVENUE THERAPEUTICS INC. | ATXI | Jin David Interim PFO and COO | 250,000 | $0 | 250,000 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 4:08 pm | N/A 2033-06-30 | AVENUE THERAPEUTICS INC. | ATXI | ROSENWALD LINDSAY A MD Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 4:08 pm | N/A 2033-06-30 | AVENUE THERAPEUTICS INC. | ATXI | KRANZLER JAY D Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 4:07 pm | N/A 2033-06-30 | AVENUE THERAPEUTICS INC. | ATXI | Oltmans Curtis Gale Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 4:07 pm | N/A 2033-06-30 | AVENUE THERAPEUTICS INC. | ATXI | Herskowitz Neil Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-06-29 Option Award | 2023-07-03 1:05 pm | N/A 2033-06-29 | AVENUE THERAPEUTICS INC. | ATXI | MacLean Alexandra Chief Executive Officer | 800,000 | $0 | 800,000 (Direct) | View |
2023-03-31 Option Award | 2023-04-04 4:08 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Fortress Biotech Inc. 10% Owner | 52,419 | $0 | 613,980 (Direct) | View |
2022-12-31 Option Award | 2023-01-04 5:49 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Fortress Biotech Inc. 10% Owner | 322,225 | $0 | 811,561 (Direct) | View |
2021-12-17 Option Award | 2021-12-21 4:26 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | KRANZLER JAY D Director | 69,020 | $0 | 133,683 (Direct) | View |
2021-12-17 Option Award | 2021-12-21 4:26 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Herskowitz Neil Director | 69,020 | $0 | 183,744 (Direct) | View |
2021-12-17 Option Award | 2021-12-21 4:24 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Oltmans Curtis Gale Director | 49,020 | $0 | 49,020 (Direct) | View |
2021-12-17 Option Award | 2021-12-20 5:08 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Lu Lucy President, CEO | 411,616 | $0 | 748,949 (Direct) | View |
2021-12-17 Option Award | 2021-12-20 5:07 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Vazzano Joseph Walter Chief Financial Officer | 100,505 | $0 | 165,757 (Direct) | View |
2020-06-16 Option Award | 2020-06-16 5:09 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | KRANZLER JAY D Director | 10,000 | $0 | 84,663 (Direct) | View |
2020-06-16 Option Award | 2020-06-16 5:09 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Herskowitz Neil Director | 10,000 | $0 | 132,224 (Direct) | View |